Login / Signup

Experiences of psychotropic medication use and decision-making for adults with intellectual disability: a multistakeholder qualitative study in the UK.

Rory SheehanAngela HassiotisAndré StrydomNicola Morant
Published in: BMJ open (2019)
Stakeholder involvement is a key element of medication optimisation that is not always experienced in decisions about psychotropic medication for people with ID. Forms of shared decision-making could be developed to promote collaboration and offer people with ID and their carers greater involvement in medication decisions.
Keyphrases
  • intellectual disability
  • decision making
  • autism spectrum disorder
  • adverse drug
  • healthcare
  • mental health